4D Molecular Therapeutics FDMT Balance Sheet

Income Statement

Quarter End	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	353.49M	324.93M	302.94M	280.16M	261.85M	244.02M	352.5M	361.61M
Total Current Assets	256.28M	243.05M	246.52M	232.48M	220.51M	207.04M	317.78M	328.24M
Cash and Equivalents	153M	75.97M	113.48M	108.3M	52.35M	78.57M	236.31M	275.68M
Total Non-Current Assets	111.6M	100.34M	77.51M	69.74M	63.6M	58.6M	56.02M	54.11M
Total Liabilities	34.38M	28.87M	30.42M	28.72M	30.51M	25.42M	27.36M	31.68M
Total Current Liabilities	16.34M	12.09M	14.33M	13.56M	15.73M	11.28M	13.75M	18.16M
Total Non-Current Liabilities	18.04M	16.78M	16.09M	15.16M	14.78M	14.14M	13.61M	13.52M
Common Equity	3k	3k	3k	3k	3k	3k	4k	4k
Retained Earnings	-207M	-233.33M	-261.42M	-287.11M	-314.49M	-343.17M	-372.79M	-383.04M

Year End December 30 2023	2018	2019	2020	2021	2022	2023
	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)	USD ($)
Total Assets	96.97M	58.23M	288.33M	353.49M	261.85M	339.89M
Total Current Assets	94.07M	52.51M	282.66M	256.28M	220.51M	296.59M
Cash and Equivalents	91.76M	49.65M	276.73M	153M	52.35M	249.11M
Total Non-Current Assets	-27.59M	-72.97M	256.39M	319.11M	231.34M	307.83M
Total Liabilities	21.58M	131.2M	31.94M	34.38M	30.51M	32.06M
Total Current Liabilities	8.05M	12.96M	16.74M	16.34M	15.73M	18.95M
Total Non-Current Liabilities	13.52M	118.25M	15.2M	18.04M	14.78M	13.11M
Total Equity	-27.59M	-72.97M	256.39M	319.11M	231.34M	307.83M
Common Equity	1,000	1,000	3k	3k	3k	4k
Retained Earnings	-30.03M	-79.03M	-135.68M	-207M	-314.49M	-415.33M